Evidence map›Paper›PMID 34927242›Full record

ArticleBritish journal of haematology2022

Identification of the minimum requirements for successful haematopoietic stem cell transplantation.

Katsuyuki Nishi, Taro Sakamaki, Kay Sadaoka, Momo Fujii, Akifumi Takaori-Kondo, James Y Chen, Masanori Miyanishi

Abstract read
In one paragraph

Article in British journal of haematology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Katsuyuki NishiRIKEN Centre for Biosystems Dynamics Research, Kobe, Hyogo, Japan.
Taro SakamakiRIKEN Centre for Biosystems Dynamics Research, Kobe, Hyogo, Japan.
Kay SadaokaRIKEN Centre for Biosystems Dynamics Research, Kobe, Hyogo, Japan.
Momo FujiiRIKEN Centre for Biosystems Dynamics Research, Kobe, Hyogo, Japan.
Akifumi Takaori-KondoDepartment of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Kyoto, Japan.
James Y ChenDivision of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Masanori MiyanishiRIKEN Centre for Biosystems Dynamics Research, Kobe, Hyogo, Japan.ORCID 0000-0002-0527-3652

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Historically, defining haematopoietic subsets, including self-renewal, differentiation and lineage restriction, has been elucidated by transplanting a small number of candidate cells with many supporting bone marrow (BM) cells. While this approach has been invaluable in characterising numerous distinct subsets in haematopoiesis, this approach is arguably flawed. The haematopoietic stem cell (HSC) has been proposed as the critical haematopoietic subset necessary for transplantation. However, due to the presence of supporting cells, the HSC has never demonstrated sufficiency. Utilising the homeobox B5 (Hoxb5)-reporter system, we found that neither long-term (LT) HSCs nor short-term (ST) HSCs alone were sufficient for long-term haematopoietic reconstitution. Critically, reconstitution can be rescued by transplanting combined LT- and ST-HSCs, without supporting cells; a fraction we term the 'Minimum Subset for Transplantation' (MST). The MST accounts for only 0·005% of nucleated cells within mouse BM, and this MST can be cultured, expanded and genetically modified while preserving its rapid haematopoietic engraftment potential. These results support the consideration of an MST approach for clinical translation, especially for gene therapy approaches that require HSC compartment modification.

Indexed as

Hematopoietic Stem Cell TransplantationQuality Indicators, Health CareAnimalsBiomarkersCell CountCell DifferentiationCell LineageCell TrackingGene ExpressionGenes, ReporterGraft SurvivalHematopoiesisHematopoietic Stem CellsHumansMiceModels, AnimalBiomarkersgene therapyhomeobox B5 (Hoxb5)long-term haematopoietic stem cellpurified haematopoietic stem cell transplantationshort-term haematopoietic stem cell

Identifiers

PMID34927242
PMCPMC9300074

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.